Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2024-04-02

FDA Approved: ATOVAQUONE — Supplemental Application (Camber Pharmaceuticals, Inc.)

View source ↗

Summary

The FDA approved Camber Pharmaceuticals' supplemental application for atovaquone.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Atovaquone (Atovaquone)

Snippet

SUPPL AP for ATOVAQUONE (ATOVAQUONE)